Trial Profile
Solitary Fibrous Tumor: Phase II Study on Trabectedin Versus Adriamycin Plus Dacarbazine in Advanced Patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2024
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary) ; Dacarbazine; Doxorubicin
- Indications Soft tissue sarcoma; Solitary-fibrous-tumour
- Focus Therapeutic Use
- Acronyms STRADA
- 09 Feb 2024 Planned number of patients changed from 50 to 23.
- 09 Feb 2024 Planned End Date changed from 1 Mar 2024 to 1 Dec 2024.
- 09 Feb 2024 Planned primary completion date changed from 1 Jan 2024 to 1 Dec 2024.